LegoChem Biosciences
Jaseong Koo began their career as a Researcher at Hanmi Pharmaceuticals in December 1999 and held this position until February 2005. Jaseong then joined HanAll BioPharma as a Director in March 2005 and remained in this role until September 2015. In October 2015, Jaseong Koo started working at Bukwang Pharmaceutical as a Director and stayed until May 2016. After that, they became the Head of CMC Center at LegoChem Biosciences in June 2016, where they are currently employed.
Jaseong Koo has a Bachelor of Science (BS) degree in Pharmacy from Woosuk University. Jaseong then pursued a Master of Science (MS) degree in Pharmaceutics from the same university. Currently, Jaseong Koo is pursuing a Doctor of Philosophy (PhD) degree in Pharmaceutics at Chungnam National University.
LegoChem Biosciences
LegoChem Biosciences, Inc. (LCB) is a research-based biotechnology company dedicated to the discovery, development, and commercialization of innovative medicines by leveraging our chemistry expertise to make conventional biologics more targeted and potent for the benefit of patients with diseases of highly unmet medical needs. We are advancing sustainable pipelines in therapeutic areas within antibiotics, anti-coagulants, oncology, antibody-drug conjugate (ADC), and protein-drug conjugate (PDC).